Wilson Therapeutics' Series B Round

Wilson Therapeutics raised a round of funding on April 16, 2014.

Wilson Therapeutics is a privately-held biopharmaceutical company focused on improving the lives of patients with Wilson's disease through development of new treatment options and support for increase…

Articles about Wilson Therapeutics' Series B Round: